| NCT04456959 |
InO - A Retrospective Study of UK Patients With Leukaemia |
https://ClinicalTrials.gov/show/NCT04456959 |
Recruiting |
Pfizer |
2020-12-31 |
| NCT03627208 |
Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Pediatric Oncology Branch |
https://ClinicalTrials.gov/show/NCT03627208 |
Enrolling by invitation |
National Institutes of Health Clinical Center (CC) |
2021-12-31 |
| NCT03374137 |
Observational Study to Monitor Safety and Effectiveness of Obinutuzumab in Follicular Lymphoma or Previously Untreated Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT03374137 |
Recruiting |
Hoffmann-La Roche |
2020-09-30 |
| NCT03342144 |
Study of the Use of Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting |
https://ClinicalTrials.gov/show/NCT03342144 |
Recruiting |
AbbVie |
2022-12-31 |
| NCT03294980 |
Chronic Lymphoid Leukaemia Observatory in Finistere Area, France |
https://ClinicalTrials.gov/show/NCT03294980 |
Recruiting |
University Hospital, Brest |
2025-11-30 |
| NCT03289182 |
An Observational Study of MabThera Subcutaneous (SC) Safety in Participants With Non-Hodgkin’s Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL) |
https://ClinicalTrials.gov/show/NCT03289182 |
Active, not recruiting |
Hoffmann-La Roche |
2020-10-26 |
| NCT03231579 |
Chronic Lymphocytic Leukemia Electronic Patient Reported Outcomes Study |
https://ClinicalTrials.gov/show/NCT03231579 |
Completed |
Carevive Systems, Inc. |
2018-11-01 |
| NCT03123887 |
Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALL |
https://ClinicalTrials.gov/show/NCT03123887 |
Completed |
Harbin Hematology and Oncology Institute |
2016-06-03 |
| NCT03067584 |
Genetic Study of Familial Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT03067584 |
Completed |
St. Jude Children’s Research Hospital |
2017-06-23 |
| NCT03059251 |
Observational Study: Safety and Effectiveness of Obinutuzumab in Chronic Lymphocytic Leukemia in Argentina |
https://ClinicalTrials.gov/show/NCT03059251 |
Completed |
Hoffmann-La Roche |
2019-03-30 |
| NCT03000335 |
Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk |
https://ClinicalTrials.gov/show/NCT03000335 |
Recruiting |
Curewize Health Ltd. |
2020-05-31 |
| NCT02915224 |
A Study of Obinutuzumab Evaluating Efficacy, Safety and Cost of Disease Management in Participants With Chronic Lymphocytic Leukemia and Comorbidities |
https://ClinicalTrials.gov/show/NCT02915224 |
Active, not recruiting |
Hoffmann-La Roche |
2020-04-30 |
| NCT02888977 |
Tyrosine Kinase Inhibitors and Low Intensity Chemotherapy in Ph+ ALL |
https://ClinicalTrials.gov/show/NCT02888977 |
Recruiting |
Versailles Hospital |
2020-12-31 |
| NCT02842229 |
A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms |
https://ClinicalTrials.gov/show/NCT02842229 |
Completed |
Celgene |
2017-02-02 |
| NCT02827617 |
Identification of Biomarkers That Are Predictive of Early Ibrutinib Treatment Failure in High Risk TP53 Mutated Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT02827617 |
Recruiting |
Oncology Institute of Southern Switzerland |
2021-02-28 |
| NCT02767388 |
Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery |
https://ClinicalTrials.gov/show/NCT02767388 |
Completed |
University of Nebraska |
2017-12-11 |
| NCT02617004 |
Multicenter Trial Treatment of Philadelphia Chromosome Negative B-cell Acute Lymphoblastic Leukemia of Young Adults |
https://ClinicalTrials.gov/show/NCT02617004 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2020-12-31 |
| NCT02582320 |
Clinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient Program |
https://ClinicalTrials.gov/show/NCT02582320 |
Recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2018-12-31 |
| NCT00923442 |
Biology Studies of Hematologic Cancers |
https://ClinicalTrials.gov/show/NCT00923442 |
Enrolling by invitation |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00268528 |
Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission |
https://ClinicalTrials.gov/show/NCT00268528 |
Completed |
Children’s Oncology Group |
2012-03-05 |
| NCT00131014 |
Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies |
https://ClinicalTrials.gov/show/NCT00131014 |
Recruiting |
Dana-Farber Cancer Institute |
2023-01-31 |
| NCT02520895 |
Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT02520895 |
Completed |
Hospices Civils de Lyon |
2013-10-31 |
| NCT02491398 |
Efficacy and Safety of Bendamustine Plus Rituximab in Chronic Lympocytic Leukemia |
https://ClinicalTrials.gov/show/NCT02491398 |
Active, not recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2018-10-31 |
| NCT02461316 |
Rituximab in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT02461316 |
Completed |
Hoffmann-La Roche |
2011-12-31 |
| NCT02434484 |
Symbenda Post-Marketing Surveillance (PMS) |
https://ClinicalTrials.gov/show/NCT02434484 |
Active, not recruiting |
Eisai Inc. |
2020-04-30 |
| NCT02414022 |
Economic Analysis of Alliance A041202 CLL Study |
https://ClinicalTrials.gov/show/NCT02414022 |
Active, not recruiting |
Canadian Cancer Trials Group |
2019-04-05 |
| NCT02381899 |
Observational Study in CLL Patients Receiving BR |
https://ClinicalTrials.gov/show/NCT02381899 |
Completed |
Czech CLL Study Group |
2016-12-31 |
| NCT02303522 |
Historical Data Analysis of Complete Remission in Children With R/R Acute Lymphoblastic Leukemia (ALL) |
https://ClinicalTrials.gov/show/NCT02303522 |
Completed |
Amgen |
2015-01-22 |
| NCT02272673 |
The Effects of Honey on Febrile Neutropenia in Children With Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT02272673 |
Completed |
Ain Shams University |
2013-08-31 |
| NCT02269592 |
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome |
https://ClinicalTrials.gov/show/NCT02269592 |
Recruiting |
Dana-Farber Cancer Institute |
2024-12-31 |
| NCT02110394 |
Ribomustin in the First Line Therapy of Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT02110394 |
Completed |
Astellas Pharma Inc |
2015-08-31 |
| NCT02080884 |
An Observational Study Examining the Effect of Added MabThera Therapy in Patients With Untreated Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT02080884 |
Completed |
Hoffmann-La Roche |
2016-12-19 |
| NCT01295476 |
Biomarker Study in Bone Marrow Samples From Patients With T-Cell Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01295476 |
Completed |
Children’s Oncology Group |
2013-05-31 |
| NCT01284010 |
Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01284010 |
Completed |
Alliance for Clinical Trials in Oncology |
2014-09-30 |
| NCT03310190 |
Study to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT03310190 |
Recruiting |
AbbVie |
2021-06-30 |
| NCT02010931 |
Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients |
https://ClinicalTrials.gov/show/NCT02010931 |
Completed |
Amgen |
2014-03-31 |
| NCT02003612 |
Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT02003612 |
Completed |
Amgen |
2014-01-31 |
| NCT01896752 |
Renal and Hepatic Clearance Following High-Dose Methotrexate in Childhood ALL |
https://ClinicalTrials.gov/show/NCT01896752 |
Completed |
Rigshospitalet, Denmark |
2013-01-31 |
| NCT01886651 |
The Influence of Thiopurine Methyltransferase Activity on Toxicity After High-dose Methotrexate in Childhood Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01886651 |
Completed |
Rigshospitalet, Denmark |
2012-02-29 |
| NCT01678508 |
Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01678508 |
Completed |
Rigshospitalet, Denmark |
2011-07-31 |
| NCT01625143 |
Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01625143 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01609023 |
A Study of Rituximab (MabThera) in Combination With Chemotherapy in Participants With CD20-Positive B-Cell Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT01609023 |
Completed |
Hoffmann-La Roche |
2015-11-30 |
| NCT01581528 |
Studying Samples From Patients With T-Cell Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01581528 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01565447 |
Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters Study |
https://ClinicalTrials.gov/show/NCT01565447 |
Active, not recruiting |
Oregon Health and Science University |
2020-12-31 |
| NCT01556386 |
Pharmacogenetic Analysis of Korean Pediatric Patients With Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01556386 |
Completed |
Seoul National University Hospital |
2012-03-31 |
| NCT01553162 |
Studying Dexamethasone and Prednisone Sensitivity in Samples From Younger Patients With High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01553162 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01540812 |
Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS |
https://ClinicalTrials.gov/show/NCT01540812 |
Completed |
PETHEMA Foundation |
2019-11-20 |
| NCT01540578 |
Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01540578 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01533168 |
Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01533168 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01505699 |
Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01505699 |
Completed |
Eastern Cooperative Oncology Group |
2012-02-06 |
| NCT01488162 |
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT01488162 |
Completed |
Hoffmann-La Roche |
2016-10-24 |
| NCT01476462 |
Second Malignant Neoplasms After Childhood ALL Therapy |
https://ClinicalTrials.gov/show/NCT01476462 |
Completed |
Rigshospitalet, Denmark |
2011-04-30 |
| NCT01470924 |
Acute Lymphoblastic Leukemia Relapse in Sweden 2003-2007 |
https://ClinicalTrials.gov/show/NCT01470924 |
Completed |
Region Örebro County |
NA |
| NCT01460238 |
Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT01460238 |
Completed |
Dartmouth-Hitchcock Medical Center |
2018-05-31 |
| NCT01453062 |
Phase IV Observational Study in Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT01453062 |
Completed |
GlaxoSmithKline |
2012-11-30 |
| NCT01439217 |
Endothelial Function, Arterial Stiffness and Components |
https://ClinicalTrials.gov/show/NCT01439217 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2013-02-28 |
| NCT01397916 |
Indoleamine 2,3-dioxygenase (IDO) Activity in Patients With Chronic Lymphocytic Leukemia (CLL) |
https://ClinicalTrials.gov/show/NCT01397916 |
Completed |
Tampere University Hospital |
2010-12-31 |
| NCT01395615 |
An Observational Study on The Health Related Quality of Life in Patients With Chronic Lymphocytic Leukaemia |
https://ClinicalTrials.gov/show/NCT01395615 |
Completed |
Hoffmann-La Roche |
2009-10-31 |
| NCT01393249 |
PEG-Asparaginase Associated Pancreatitis, Hepatotoxicity and Hyperlipidemia in Children With ALL |
https://ClinicalTrials.gov/show/NCT01393249 |
Completed |
Rigshospitalet, Denmark |
2013-12-31 |
| NCT01380587 |
Utility of XCL1 as a Prognostic Marker in Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01380587 |
Completed |
Hospital Universitario Dr. Jose E. Gonzalez |
2012-09-30 |
| NCT04364451 |
Correlation of Polymorphisms of Lipoprotein Lipase (LpL) and Apolipoprotein E (Apo E) With Lipid Profile of Children With Acute Lymphoblastic Eukaemia During Therapy With L - Asparaginase. |
https://ClinicalTrials.gov/show/NCT04364451 |
Recruiting |
Aristotle University Of Thessaloniki |
2022-08-31 |
| NCT04322084 |
Continuous Ambulatory Monitoring to Predict Elevated Risk of Infection in Children With Lymphoblastic Leukemia Undergoing Induction Chemotherapy (CAMPER-ALL) |
https://ClinicalTrials.gov/show/NCT04322084 |
Recruiting |
St. Jude Children’s Research Hospital |
2021-05-01 |
| NCT04290000 |
Collection of Biological Samples From Patients Treated With CAR-T Cells for Hematological Malignancies |
https://ClinicalTrials.gov/show/NCT04290000 |
Recruiting |
University Hospital, Montpellier |
2025-02-25 |
| NCT04290923 |
Determination of Blood Tumor Cells |
https://ClinicalTrials.gov/show/NCT04290923 |
Recruiting |
University of Zurich |
2020-09-30 |
| NCT04271215 |
Overweight and Obesity as Prognostic Factors for Survival in Children With Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT04271215 |
Recruiting |
Coordinación de Investigación en Salud, Mexico |
2020-12-31 |
| NCT04198415 |
A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia) |
https://ClinicalTrials.gov/show/NCT04198415 |
Recruiting |
AbbVie |
2022-03-31 |
| NCT04187248 |
The Association Between Asparaginase Enzyme Activity Levels and Toxicities in Childhood Acute Lymphoblastic Leukaemia in NOPHOALL 2008 |
https://ClinicalTrials.gov/show/NCT04187248 |
Completed |
Aarhus University Hospital |
2016-02-28 |
| NCT04178317 |
A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT04178317 |
Recruiting |
AbbVie |
2026-03-25 |
| NCT04159779 |
A Study of Clinical Outcomes in Relapse/Refractory Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece |
https://ClinicalTrials.gov/show/NCT04159779 |
Recruiting |
AbbVie |
2020-11-25 |
| NCT04055558 |
Lymphoproliferative Disorders During the Treatment of Childhood Acute Lymphoblastic Leukemia/Lymphoma |
https://ClinicalTrials.gov/show/NCT04055558 |
Recruiting |
Rabin Medical Center |
2019-12-18 |
| NCT04028531 |
Understanding Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT04028531 |
Recruiting |
Dana-Farber Cancer Institute |
2024-09-29 |
| NCT04016636 |
A Study to Evaluate Impact of Ibrutinib on the Quality of Life (QOL) in Patients With Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT04016636 |
Recruiting |
Fundaleu |
2021-08-31 |
| NCT03974893 |
Dietary Intake, Sarcopenic Obesity, and Other Treatment-Related Outcomes in Indian Children With Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT03974893 |
Recruiting |
Columbia University |
2021-11-30 |
| NCT03985826 |
Primary Health Care Utilisation Among Survivors of Childhood Acute Lymphoblastic Leukaemia |
https://ClinicalTrials.gov/show/NCT03985826 |
Completed |
University of Aarhus |
2019-11-30 |
| NCT03971565 |
Evaluation of the Redox Profiles of Healthy and Pathological B Cells in Patients With Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT03971565 |
Recruiting |
Assistance Publique Hopitaux De Marseille |
2021-03-18 |
| NCT03911128 |
A Treatment Protocol for Participants 1-45 Years With Acute Lymphoblastic Leukaemia |
https://ClinicalTrials.gov/show/NCT03911128 |
Recruiting |
Karolinska University Hospital |
2020-03-31 |
| NCT03898128 |
ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Immunoconjugate |
https://ClinicalTrials.gov/show/NCT03898128 |
Recruiting |
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori |
2020-10-31 |
| NCT03873857 |
A Study to Assess Effectiveness of Venclexta (Venetoclax) in Patients With Relapse or Refractory Chronic Lymphocytic Leukemia in Routine Clinical Practice in Russian Federation |
https://ClinicalTrials.gov/show/NCT03873857 |
Recruiting |
AbbVie |
2022-12-03 |
| NCT03847727 |
Bendamustine and Rituximab (BR) as Induction and Maintenance in Relapsed and Refractory Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT03847727 |
Active, not recruiting |
Pirogov Russian National Research Medical University |
2019-12-03 |
| NCT03803670 |
Clinical Significance of Occult Central Nervous System Disease In Adult Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT03803670 |
Completed |
University of Rome Tor Vergata |
2019-01-01 |
| NCT03751072 |
Efficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO) |
https://ClinicalTrials.gov/show/NCT03751072 |
Recruiting |
Group for Research in Adult Acute Lymphoblastic Leukemia |
2018-11-30 |
| NCT03720561 |
A Study to Evaluate Ibrutinib Retention in Chronic Lymphocytic Leukemia Participants Treated in a Real World Setting |
https://ClinicalTrials.gov/show/NCT03720561 |
Active, not recruiting |
Janssen-Cilag S.p.A. |
2021-10-31 |
| NCT03678454 |
Iclusig® (Ponatinib) in Clinical Practice for the Treatment of Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia in Belgium |
https://ClinicalTrials.gov/show/NCT03678454 |
Recruiting |
Incyte Corporation |
2022-03-31 |
| NCT03659669 |
A Study to Describe the Effectiveness and Safety of Venetoclax Treatment in Chronic Lymphocytic Leukemia (CLL) Patients in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT03659669 |
Recruiting |
AbbVie |
2024-10-31 |
| NCT03582098 |
Clinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and Ireland |
https://ClinicalTrials.gov/show/NCT03582098 |
Completed |
Gilead Sciences |
2019-03-26 |
| NCT03581045 |
Postural Control Under Different Cognitive Loads in Adult Survivors of Acute Lymphoblastic Leukemia and Age-Matched Healthy Individuals |
https://ClinicalTrials.gov/show/NCT03581045 |
Active, not recruiting |
St. Jude Children’s Research Hospital |
2020-06-30 |
| NCT03568266 |
Pharmacogenomics of Asparaginase Induced Hepatotoxicity |
https://ClinicalTrials.gov/show/NCT03568266 |
Recruiting |
University of Southern California |
2024-05-22 |
| NCT03545659 |
Childhood Acute Lymphoblastic Leukaemia: Follow-Up |
https://ClinicalTrials.gov/show/NCT03545659 |
Recruiting |
University of Aarhus |
2020-06-30 |
| NCT03528941 |
The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With Ibrutinib |
https://ClinicalTrials.gov/show/NCT03528941 |
Recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2020-08-31 |
| NCT03471416 |
Nutritional Status in Children With ALL in Guatemala |
https://ClinicalTrials.gov/show/NCT03471416 |
Recruiting |
Columbia University |
2021-01-31 |
| NCT03476655 |
Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From India |
https://ClinicalTrials.gov/show/NCT03476655 |
Completed |
Johnson & Johnson Private Limited |
2019-05-14 |
| NCT03436524 |
A Prognostic Tool for Early Stage CLL |
https://ClinicalTrials.gov/show/NCT03436524 |
Recruiting |
Oncology Institute of Southern Switzerland |
2020-02-28 |
| NCT03425591 |
A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT03425591 |
Recruiting |
Janssen-Cilag Ltd. |
2022-05-22 |
| NCT03415035 |
Study Venetoclax Effectiveness and Realâ€Life Treatment Management in Participants With Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT03415035 |
Recruiting |
AbbVie |
2022-03-30 |
| NCT01224093 |
An Observational Study on the Safety Profile of MabThera/Rituxan (Rituximab) in Combination With Chemotherapy in Patients With B Cell-lineage Chronic Lymphocytic Leukaemia (MABERYC) |
https://ClinicalTrials.gov/show/NCT01224093 |
Completed |
Hoffmann-La Roche |
2014-02-28 |
| NCT01199562 |
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT01199562 |
Completed |
City of Hope Medical Center |
2013-12-31 |
| NCT01185886 |
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01185886 |
Active, not recruiting |
European Organisation for Research and Treatment of Cancer - EORTC |
2021-06-30 |
| NCT01178086 |
A Study on Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL) |
https://ClinicalTrials.gov/show/NCT01178086 |
Completed |
Hoffmann-La Roche |
2015-06-30 |
| NCT01148927 |
Quality of Life Study for Adult Patients With Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01148927 |
Completed |
University Health Network, Toronto |
2012-06-30 |
| NCT01142427 |
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01142427 |
Active, not recruiting |
Children’s Oncology Group |
2015-05-01 |
| NCT01144793 |
Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias |
https://ClinicalTrials.gov/show/NCT01144793 |
Completed |
Stanford University |
2008-06-30 |
| NCT01119586 |
Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01119586 |
Completed |
Children’s Oncology Group |
2015-12-31 |
| NCT01117142 |
A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01117142 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01110863 |
Characterization of Proliferating Compartment in B-Cell Patients and in Healthy Aging Subjects |
https://ClinicalTrials.gov/show/NCT01110863 |
Completed |
Northwell Health |
2016-02-12 |
| NCT01110850 |
Direct Measurement of Leukemic Cell Turnover (Synthesis and Removal) in Patients With Chronic Lymphocytic Leukemia (CLL) Using Deuterated Water |
https://ClinicalTrials.gov/show/NCT01110850 |
Completed |
Northwell Health |
2018-05-31 |
| NCT01094392 |
Hemostasis During Asparaginase Treatment in Acute Lymphoblastic Leukemia(ALL) |
https://ClinicalTrials.gov/show/NCT01094392 |
Recruiting |
Aarhus University Hospital |
2019-12-31 |
| NCT01081015 |
Connectâ„¢ CLL: The Chronic Lymphocytic Leukemia Disease Registry |
https://ClinicalTrials.gov/show/NCT01081015 |
Completed |
Celgene |
2017-12-31 |
| NCT01078337 |
T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis |
https://ClinicalTrials.gov/show/NCT01078337 |
Completed |
Stanford University |
2007-10-31 |
| NCT01072240 |
An Observational Study on Infusion-related Adverse Events at Administration of MabThera (Rituximab) in Patients With Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT01072240 |
Completed |
Hoffmann-La Roche |
2011-06-30 |
| NCT01047020 |
Motor Proficiency And Physical Activity in Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL) |
https://ClinicalTrials.gov/show/NCT01047020 |
Completed |
St. Jude Children’s Research Hospital |
2013-04-30 |
| NCT01030913 |
B-type Chronic Lymphocytic Leukemia (B-CLL) Subgroups: Maturation Stage and Gene Expression |
https://ClinicalTrials.gov/show/NCT01030913 |
Recruiting |
Northwell Health |
2021-01-31 |
| NCT01028430 |
B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging |
https://ClinicalTrials.gov/show/NCT01028430 |
Recruiting |
Northwell Health |
2021-01-31 |
| NCT01014195 |
Risk of Psychopathology and Neurocognitive Impairment in Leukemia Survivors |
https://ClinicalTrials.gov/show/NCT01014195 |
Completed |
St. Jude Children’s Research Hospital |
2014-10-31 |
| NCT01016379 |
Studying DNA in Blood and Bone Marrow Samples From Young Patients With Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01016379 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01005368 |
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT01005368 |
Active, not recruiting |
Alliance for Clinical Trials in Oncology |
2100-01-31 |
| NCT00993135 |
Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT00993135 |
Completed |
Vanderbilt University Medical Center |
2009-12-31 |
| NCT00923507 |
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL) |
https://ClinicalTrials.gov/show/NCT00923507 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00897325 |
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT00897325 |
Completed |
Children’s Oncology Group |
2019-12-31 |
| NCT00898755 |
Collecting and Storing Tissue From Young Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00898755 |
Completed |
Children’s Oncology Group |
2008-07-17 |
| NCT00896766 |
Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT00896766 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT00898404 |
Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate |
https://ClinicalTrials.gov/show/NCT00898404 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT03860376 |
Ex Vivo Drug Sensitivity Testing and Mutation Profiling |
https://ClinicalTrials.gov/show/NCT03860376 |
Recruiting |
Florida International University |
2022-12-15 |
| NCT03647215 |
CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey |
https://ClinicalTrials.gov/show/NCT03647215 |
Recruiting |
Incyte Corporation |
2020-06-30 |
| NCT03279900 |
Hematotoxicity in Acute Lymphoblastic Leukemia Children in Maintenance Phase Therapy |
https://ClinicalTrials.gov/show/NCT03279900 |
Completed |
Indonesia University |
2018-05-16 |
| NCT03633045 |
Observational Study of Ibrutinib Use in CLL |
https://ClinicalTrials.gov/show/NCT03633045 |
Recruiting |
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health |
2021-09-30 |
| NCT00801346 |
Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission |
https://ClinicalTrials.gov/show/NCT00801346 |
Completed |
Vanderbilt University Medical Center |
2016-04-30 |
| NCT04437420 |
Preclinical Project on the Traitment of Acute Lymphoblastique Leukemia With NVP-BEP800, an Inhibitor of the Heat Shock Protein HSP90 |
https://ClinicalTrials.gov/show/NCT04437420 |
Recruiting |
Centre Hospitalier Universitaire Dijon |
2021-09-30 |
| NCT02783651 |
An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US |
https://ClinicalTrials.gov/show/NCT02783651 |
Completed |
Amgen |
2020-03-31 |
| NCT00664131 |
Neurologic Morbidity and Disability in Acute Lymphoblastic Leukemia Survivors |
https://ClinicalTrials.gov/show/NCT00664131 |
Completed |
St. Jude Children’s Research Hospital |
2008-10-31 |
| NCT00626496 |
Family Study of Lymphoproliferative Disorders |
https://ClinicalTrials.gov/show/NCT00626496 |
Recruiting |
Mayo Clinic |
2025-12-31 |
| NCT00552825 |
Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children |
https://ClinicalTrials.gov/show/NCT00552825 |
Completed |
Sheba Medical Center |
NA |
| NCT00505141 |
Urban Environmental Exposures and Childhood Cancer |
https://ClinicalTrials.gov/show/NCT00505141 |
Completed |
Georgetown University |
NA |
| NCT00503256 |
Genetic Study of Chronic Lymphocytic Leukemia Families |
https://ClinicalTrials.gov/show/NCT00503256 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2019-09-30 |
| NCT00482352 |
Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT00482352 |
Completed |
Children’s Oncology Group |
2012-04-30 |
| NCT00481858 |
Kinetic Biomarker for Chronic Lymphocytic Leukemia Prognosis |
https://ClinicalTrials.gov/show/NCT00481858 |
Completed |
KineMed |
2010-07-31 |
| NCT00437060 |
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT00437060 |
Completed |
Children’s Oncology Group |
2015-09-30 |
| NCT00344825 |
Vitalis Study - Observational Study on the Quality of Life in Patients Under Treatment for B-Chronic Lymphocytic Leukemia (B-CLL) |
https://ClinicalTrials.gov/show/NCT00344825 |
Completed |
Sanofi |
2006-11-30 |
| NCT00339664 |
Analyses of Human Samples Collected in Clinical Trials |
https://ClinicalTrials.gov/show/NCT00339664 |
Completed |
National Institutes of Health Clinical Center (CC) |
2020-03-17 |
| NCT00330538 |
Osteoporosis in Children With ALL |
https://ClinicalTrials.gov/show/NCT00330538 |
Completed |
Children’s Mercy Hospital Kansas City |
NA |
| NCT00085176 |
Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT00085176 |
Completed |
Children’s Oncology Group |
2009-09-30 |
| NCT00048958 |
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma |
https://ClinicalTrials.gov/show/NCT00048958 |
Active, not recruiting |
Alliance for Clinical Trials in Oncology |
2100-01-31 |
| NCT00003861 |
Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia |
https://ClinicalTrials.gov/show/NCT00003861 |
Active, not recruiting |
Alliance for Clinical Trials in Oncology |
2100-01-31 |